Clustered regularly interspaced short palindromic repeats (CRISPR)-based therapeutics are rapidly gaining traction for the management of infectious diseases. Programs targeting pathogens such as the ...

Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025Additional orphan designation underscores Sanofi commitment to advancing ...

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life ...

Med spas together with hospital systems have started compressing private practices; Dr. Meegan Gruber urges patients to ...

Bayer has inked a global licensing deal with Kumquat Biosciences for a KRAS G12D cancer drug, allowing Phase 1a trials to be ...

Black Book's 18-country survey reveals 74% of health systems advancing large-scale rollouts by 2027, fueled by ...

Stoke Therapeutics and Biogen have begun dosing in the global Phase III EMPEROR study of zorevunersen for Dravet syndrome, ...

GENEVAD, SE / ACCESS Newswire / August 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering ...

The global refurbished ultrasound devices market is set to witness a CAGR of ~8% in the next 5 years. Cost effectiveness & ...

The global wireless fetal monitoring system market is set to witness a CAGR of ~7% in the next 5 years. Increasing adoption ...

The global laboratory automation market is set to witness a growth rate of ~7% during the forecast period. Integration of ...

The global orthopedic implants market is expected to grow at a CAGR of ~4% during the forecast period. Increasing geriatric ...